The Lancet Diabetes & Endocrinology

The Lancet Diabetes & Endocrinology, dedicated to covering the disciplines of diabetes, endocrinology, and metabolism, is the latest title in The Lancet family of specialty journals. Continuing in The Lancet's tradition of publishing high-impact content that influences medical practice, each monthly issue of The Lancet Diabetes & Endocrinology will contain Original Research, Reviews, Comments, and News. The Lancet Diabetes & Endocrinology is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. Original Research is fast-tracked to publication within 8 weeks on average of submission and published Online First on TheLancet.com before the print issue.

Publisher
Lancet
Website
http://www.thelancet.com/journals/landia/onlinefirst

Some content from Wikipedia, licensed under CC BY-SA

Health

Hormones are not the key to younger women's sexual function

A Monash University study into the causes of sexual dysfunction in young women has found social factors play just as important a role as hormone levels, and hormone therapy should not be prescribed as the only treatment.

Diseases, Conditions, Syndromes

Highlighting diabetes risks in COVID-19

An international review involving Monash University has found elderly people with diabetes who contract COVID-19 are at a much higher risk of dying from the disease—and the virus may actually trigger the onset of diabetes ...

Diseases, Conditions, Syndromes

SGLT2 inhibitors protect against kidney disease in T2DM

(HealthDay)—A class of diabetes drugs, called sodium-glucose co-transporter-2 (SGLT2) inhibitors, protect against kidney disease in patients with type 2 diabetes, according to a review published online Sept. 5 in The Lancet ...

page 1 from 9